相关实验视频
Updated: Jul 15, 2025

18:48
Murine Renal Transplantation Procedure
Published on: July 10, 2009
29.8K
在卡斯特曼病中成功移植脏 - - 印度的第一份病例报告
Sanjay Maitra1, Dhruva Maitra2, Swarnalata Gowrishankar2
1Department of Nephrology, Apollo Health City, Hyderabad, Telangana, India.
Indian journal of nephrology
|October 2, 2023
概括
这项研究详细介绍了一例罕见的多中心卡斯特曼病 (CD) 在透析期末病 (ESRD) 患者中发展的罕见病例. 患者在治疗后成功接受了移植,突出显示了一种罕见但可行的治疗选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 卡斯特曼病 (CD) 是一种罕见的淋巴增殖性疾病,表现不同.
- 在CD中脏参与是不常见的,通常与血细胞类型相关,并可能导致末期脏疾病 (ESRD).
- 虽然已有证据表明CD进展为ESRD,但透析患者发展CD的情况非常罕见,CD患者的脏移植也是如此.
研究的目的:
- 报告一个独特的病例,患者患有未知病因的ESRD,在接受透析时发展出多中心CD.
- 在这种罕见的临床场景中记录治疗和成功的移植.
- 为增加有关卡斯特曼病患者移植结果的有限文献做出贡献.
主要方法:
- 一个患有ESRD的患者的病例报告,该患者患有多中心性CD.
- 进行的治疗包括四剂Rituximab.
- 患者接受了活体捐赠者的移植.
主要成果:
- 患有ESRD的患者在透析期间发展出多中心卡斯特曼病.
- 获得了成功的Rituximab治疗和随后的活体捐赠者的移植.
- 患者在移植后仍然在临床上表现良好.
结论:
- 这一案例代表了一例罕见的透析患者发展多中心性CD.
- 在患有ESRD的CD患者中,在Rituximab治疗后成功移植脏是可行的.
- 这可能是第一个报告的成功移植在CD与ESRD患者从印度.
相关概念视频
Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
Kidney Transplant II: Surgical Procedure
22
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
22

